دورية أكاديمية
MA13.06 Amivantamab, Lazertinib Plus Platinum-based Chemotherapy in EGFR-mutated Advanced NSCLC: Updated Results from CHRYSALIS-2.
| العنوان: | MA13.06 Amivantamab, Lazertinib Plus Platinum-based Chemotherapy in EGFR-mutated Advanced NSCLC: Updated Results from CHRYSALIS-2. |
|---|---|
| المؤلفون: | Lee, S.-H., Cho, B.C., Spira, A.I., Ou, S.-H.I., Waqar, S.N., Shah, S., Trani, L., Chu, P.-L., Thayu, M., Knoblauch, R.E., Bauml, J.M., Marmarelis, M.E. |
| المصدر: | Journal of Thoracic Oncology; 2023 Supplement, Vol. 18 Issue 11, pS146-S147, 2p |
| قاعدة البيانات: | Complementary Index |
| تدمد: | 15560864 |
|---|---|
| DOI: | 10.1016/j.jtho.2023.09.208 |